MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
580.60%
Quick Ratio
420.08%
Cash Ratio
280.20%
Debt to Asset Ratio
27.69%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Deferred tax assets
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accounts payable and accrued lia...
    • Retained earnings
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
2,222,435 1,311,679 1,250,108 1,213,816
Short-term investments
0 248,930 227,731 218,309
Accounts receivable, net
903,914 908,214 790,266 855,855
Inventory
1,273,221 1,298,883 1,382,173 1,340,169
Other current assets
205,500 185,784 204,265 177,183
Total current assets
4,605,070 3,953,490 3,854,543 3,805,332
Long-term investments
0 492,242 512,937 508,592
Property, plant and equipment, net
958,071 952,508 1,038,187 1,030,385
Intangible assets, net
204,662 213,837 233,112 239,620
Goodwill
196,199 196,199 196,199 196,199
Deferred tax assets
1,500,598 1,508,697 1,509,109 1,427,021
Restricted cash equivalents
850,000 NaN NaN NaN
Other assets
276,416 277,049 270,781 249,192
Total assets
8,591,016 7,594,022 7,614,868 7,456,341
Accounts payable and accrued liabilities
793,152 759,031 798,438 684,247
Total current liabilities
793,152 759,031 798,438 684,247
Long-term convertible debt, net
NaN 597,176 596,663 596,162
Long-term debt, net
1,430,282 NaN NaN NaN
Other long-term liabilities
155,475 150,816 163,056 148,819
Total liabilities
2,378,909 1,507,023 1,558,157 1,429,228
Common stock, 0.001 par value 500,000,000 shares authorized 193,268,870 and 192,300,101 shares issued and outstanding, respectively
193 192 192 192
Additional paid-in capital
5,966,868 5,956,582 5,900,968 5,851,637
Company common stock held by the nonqualified deferred compensation plan
10,450 10,508 11,291 11,674
Accumulated other comprehensive loss
-4,237 -13,473 -33,937 -44,565
Retained earnings
259,733 154,206 200,779 231,523
Total stockholders equity
6,212,107 6,086,999 6,056,711 6,027,113
Total liabilities and stockholders equity
8,591,016 7,594,022 7,614,868 7,456,341
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$2,222,435K (111.90%↑ Y/Y)Inventory$1,273,221K (-0.13%↓ Y/Y)Accounts receivable, net$903,914K (22.29%↑ Y/Y)Other current assets$205,500K (13.20%↑ Y/Y)Total current assets$4,605,070K (32.79%↑ Y/Y)Deferred tax assets$1,500,598K (2.74%↑ Y/Y)Property, plant andequipment, net$958,071K (-7.22%↓ Y/Y)Restricted cashequivalents$850,000K Other assets$276,416K (17.30%↑ Y/Y)Intangible assets, net$204,662K (-17.26%↓ Y/Y)Goodwill$196,199K (0.00%↑ Y/Y)Total assets$8,591,016K (20.20%↑ Y/Y)Total liabilities andstockholders equity$8,591,016K (20.20%↑ Y/Y)Total stockholdersequity$6,212,107K (7.23%↑ Y/Y)Total liabilities$2,378,909K (75.75%↑ Y/Y)Company common stockheld by the...$10,450K (-6.50%↓ Y/Y)Accumulated othercomprehensive loss-$4,237K (-122.12%↓ Y/Y)Additional paid-in capital$5,966,868K (2.98%↑ Y/Y)Retained earnings$259,733K (2983.04%↑ Y/Y)Long-term debt, net$1,430,282K Total currentliabilities$793,152K (26.26%↑ Y/Y)Other long-termliabilities$155,475K (19.89%↑ Y/Y)Common stock, 0.001 parvalue 500,000,000...$193K (0.52%↑ Y/Y)Accounts payable andaccrued liabilities$793,152K (26.26%↑ Y/Y)

biomarin-logo-svg

BIOMARIN PHARMACEUTICAL INC (BMRN)

biomarin-logo-svg

BIOMARIN PHARMACEUTICAL INC (BMRN)